ATE518139T1 - Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers - Google Patents

Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers

Info

Publication number
ATE518139T1
ATE518139T1 AT07802440T AT07802440T ATE518139T1 AT E518139 T1 ATE518139 T1 AT E518139T1 AT 07802440 T AT07802440 T AT 07802440T AT 07802440 T AT07802440 T AT 07802440T AT E518139 T1 ATE518139 T1 AT E518139T1
Authority
AT
Austria
Prior art keywords
receptor antibody
diagnosing
receptor
disease involving
disease
Prior art date
Application number
AT07802440T
Other languages
English (en)
Inventor
Kai Schulze-Forster
Harald Heidecke
Original Assignee
Celltrend Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltrend Gmbh filed Critical Celltrend Gmbh
Application granted granted Critical
Publication of ATE518139T1 publication Critical patent/ATE518139T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT07802440T 2006-08-04 2007-07-31 Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers ATE518139T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06016296A EP1884775B1 (de) 2006-08-04 2006-08-04 Verfahren zur Diagnose einer Erkrankung mit Beteiligung eines Anti-AT1-Rezeptor-Antikörpers
PCT/EP2007/057910 WO2008015218A2 (en) 2006-08-04 2007-07-31 Method for diagnosis of a disease involving an anti-at1-receptor antibody

Publications (1)

Publication Number Publication Date
ATE518139T1 true ATE518139T1 (de) 2011-08-15

Family

ID=37401029

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06016296T ATE454630T1 (de) 2006-08-04 2006-08-04 Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpers
AT07802440T ATE518139T1 (de) 2006-08-04 2007-07-31 Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06016296T ATE454630T1 (de) 2006-08-04 2006-08-04 Verfahren zur diagnose einer erkrankung mit beteiligung eines anti-at1-rezeptor-antikörpers

Country Status (7)

Country Link
US (1) US8425877B2 (de)
EP (2) EP1884775B1 (de)
AT (2) ATE454630T1 (de)
DE (1) DE602006011602D1 (de)
ES (2) ES2336350T3 (de)
PL (2) PL1884775T3 (de)
WO (1) WO2008015218A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10123929A1 (de) 2001-05-11 2002-11-21 Celltrend Gmbh Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit
EP1884776A1 (de) * 2006-08-04 2008-02-06 Celltrend GmbH Verfahren zur diagnose einer krankheit, die auf der gegenwart des anti-endothelin-antikörpers beruht
PL1884775T3 (pl) 2006-08-04 2010-06-30 Celltrend Gmbh Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1
BR112012026006A2 (pt) * 2010-04-12 2019-09-24 Cell Trend GmbH método para diagnose de esclerose múltipla envolvendo anticorpo antirreceptor at1
US8483415B2 (en) 2010-06-18 2013-07-09 Motorola Mobility Llc Antenna system with parasitic element for hearing aid compliant electromagnetic emission
US10648977B2 (en) 2015-10-30 2020-05-12 The Johns Hopkins University Angiotensin receptor autoantibodies as biomarker for effected usage of angiotensin receptor blockers
WO2017123550A1 (en) * 2016-01-11 2017-07-20 Autotelic Llc Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
CN108948183B (zh) * 2018-06-05 2022-01-28 武汉华纪元生物技术开发有限公司 α1受体和AT1受体抗原类似物多肽及其抗体检测试剂盒和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2866182B2 (ja) 1990-10-08 1999-03-08 日本ケミファ株式会社 エンドセリン受容体
FR2787330A1 (fr) 1998-12-18 2000-06-23 Sanofi Sa Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe
JP2002539075A (ja) 1998-12-24 2002-11-19 マックス−デルブルック−セントラム フュール モレクラーレ メディツィン Ａｔ１受容体のペプチド、及び子癇前症、悪性高血圧症におけるその使用
DE19954305A1 (de) 1998-12-24 2000-06-29 Max Delbrueck Centrum Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie
CA2314811A1 (en) * 2000-08-02 2002-02-02 Brian Archibald Macvicar Autoimmunity to angiotensin at1 receptors in schizophrenia
DE10123929A1 (de) * 2001-05-11 2002-11-21 Celltrend Gmbh Verfahren zur Vorhersage eines Transplantatabstoßungsrisikos und immunologischer Testkit
US20030078190A1 (en) * 2001-05-25 2003-04-24 Weinberg Marc S. Methods for tissue protection using highly effective inhibition of the renin-angiotensin system
EP1570272A2 (de) * 2002-11-29 2005-09-07 Max-Delbrück-Centrum Für Molekulare Medizin Bestimmung agonistischer autoantikörper
US20060135422A1 (en) * 2003-04-17 2006-06-22 Moskowitz David W Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE
WO2006060336A2 (en) 2004-11-30 2006-06-08 The Johns Hopkins University Endothelin-2 and retinal damage
EP1884776A1 (de) 2006-08-04 2008-02-06 Celltrend GmbH Verfahren zur diagnose einer krankheit, die auf der gegenwart des anti-endothelin-antikörpers beruht
PL1884775T3 (pl) 2006-08-04 2010-06-30 Celltrend Gmbh Sposób rozpoznawania chorób związanych z przeciwciałem przeciwko receptorowi AT 1

Also Published As

Publication number Publication date
EP1884775A1 (de) 2008-02-06
PL2057467T3 (pl) 2011-12-30
US20100098688A1 (en) 2010-04-22
EP1884775B1 (de) 2010-01-06
WO2008015218A2 (en) 2008-02-07
PL1884775T3 (pl) 2010-06-30
US8425877B2 (en) 2013-04-23
DE602006011602D1 (de) 2010-02-25
ES2336350T3 (es) 2010-04-12
EP2057467A2 (de) 2009-05-13
ES2369798T3 (es) 2011-12-07
WO2008015218A3 (en) 2008-07-03
EP2057467B1 (de) 2011-07-27
ATE454630T1 (de) 2010-01-15

Similar Documents

Publication Publication Date Title
ATE518139T1 (de) Verfahren zur diagnose einer krankheit mit beteiligung eines anti-at1-rezeptor-antikörpers
NZ592358A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2)
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE550658T1 (de) Verfahren für den nachweis oder die diagnose neurodegenerativer erkrankungen oder leiden
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
EP3264090A3 (de) Verfahren zur erkennung von nukleosomaddukten
AR086734A1 (es) Metodos de diagnostico de la enfermedad tromboembolica
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
DE502006008028D1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
NZ600160A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CY1122202T1 (el) Προσδιορισμος κινδυνου για θεραπεια αντιβιοτικων σε ασθενεις οι οποιοι υποφερουν απο πρωτοπαθη μη μολυσματικη νοσο δια καθορισμου του επιπεδου προκαλσιτονινης
DE602007007775D1 (de) Reagenz für hämoglobinabbau
EP1977234A4 (de) Moleküle zur behandlung von lungenerkrankungen mit einer immunreaktion mit verbindungsgewebe in der lunge
DE602006002490D1 (de) Verfahren zur diagnose von tumoren
DE602006020850D1 (de) Biomarker zur diagnose einer herzerkrankung sowie verwendung davon
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
ATE528651T1 (de) Diagnoseverfahren für pulmonale arterielle hypertonie
CY1111602T1 (el) ΜΕΘΟΔΟΣ ΓΙΑ ΤΗΝ ΑΝΙΧΝΕΥΣΗ ΤΗΣ ΔΡΑΣΤΙΚΟΤΗΤΑΣ IN VIVO ΤΗΣ ΝΕΥΡΟΤΡΥΨΙΝΗΣ, ΧΡΗΣΗ ΤΗΣ ΜΕΘΟΔΟΥ ΚΑΙ ΧΡΗΣΗ TOY C-ΤΕΡΜΑΤΙΚΟΥ 22-kDa ΘΡΑΥΣΜΑΤΟΣ ΤΗΣ ΑΓΡΙΝΗΣ ΩΣ ΒΙΟΔΕΙΚΤΗ ΕΙΣ ΤΗΝ ΔΙΑΓΝΩΣΗ ΚΑΙ ΠΑΡΑΚΟΛΟΥΘΗΣΗ ΔΙΑΤΑΡΑΧΩΝ ΠΟΥ ΕΧΟΥΝ ΣΧΕΣΗ ΜΕ ΝΕΥΡΟΤΡΥΨΙΝΗ
FR2946349B1 (fr) Sequences, anticorps, procedes et necessaires pour la detection et le dosage in vitro de la periostine, en vue du diagnostic du suivi ou du pronostic de pathologies ou de phenomenes biologiques impliquant la periostine
RU2009146803A (ru) Способ диагностики деструктивного панкреатита
BR112013030646A2 (pt) uso diagnóstico de pró-somatostatina
ATE509270T1 (de) Aus blutplättchen gewonnene mikropartikel als neue diagnosemarker für eine herz-kreislauf- erkrankung
ATE528650T1 (de) Verfahren zum nachweis und zur diagnose einer infektion mit trypanosoma cruzi
WO2010093214A3 (en) Monoclonal antibody recognizing scye1 and use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2057467

Country of ref document: EP